A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.

The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.

The Apple Watch Series 12 is cheaper than ever ahead of Black Friday
- 5 hours ago

Voyager 1 is about to reach a mind-bending milestone
- 12 hours ago

What the midterms taught us
- 12 hours ago

Trump’s looming nominations crunch
- 3 hours ago

Tech leaders are convinced that Jensen Huang’s exit was a plot against him
- 14 hours ago

NationalGrid plans Rs100bn Sukuk programme to strengthen Pakistan’s electricity transmission network
- 27 minutes ago

US data centers now burn more electricity than a midsized country
- 5 hours ago

Robert Pattinson is Amazon’s first James Bond
- 14 hours ago

CDF munir vows to eliminate menace of terrorism in KP
- an hour ago

The case for new Democratic leadership
- 12 hours ago

The US has officially lost control of measles
- 12 hours ago

Democrats won big. Now they’re arguing about why.
- 12 hours ago















